Who are noradrenaline and vascular filling's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): CarVeDilol-SR (Slow Release), Comparator: carvedilol, Lumify®, Norepinephrine intra-arteriel/hepatic, Brompheniramine + pseudoephedrine, Placebo to Prazosin.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/noradrenaline-and-vascular-filling.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

noradrenaline and vascular filling — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

noradrenaline and vascular filling (noradrenaline and vascular filling) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Sympathomimetic. Area: Cardiovascular.

phase 3 Sympathomimetic Alpha-1 adrenergic receptor Cardiovascular Small molecule Live · refreshed every 30 min

Target snapshot

noradrenaline and vascular filling (noradrenaline and vascular filling) — Centre Hospitalier Universitaire, Amiens. Noradrenaline increases vascular tone and cardiac contractility by stimulating alpha-1 adrenergic receptors.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
noradrenaline and vascular filling TARGET	noradrenaline and vascular filling	Centre Hospitalier Universitaire, Amiens	phase 3	Sympathomimetic	Alpha-1 adrenergic receptor
CarVeDilol-SR (Slow Release)	CarVeDilol-SR (Slow Release)	Seoul National University Bundang Hospital	marketed	Beta-blocker with alpha-1 blocking activity	Beta-1 adrenergic receptor, Beta-2 adrenergic receptor, Alpha-1 adrenergic receptor
Comparator: carvedilol	Comparator: carvedilol	Organon and Co	marketed	Beta-blocker with alpha-1 antagonist activity	Beta-1 adrenergic receptor, Beta-2 adrenergic receptor, Alpha-1 adrenergic receptor
Lumify®	Lumify®	Bausch & Lomb Incorporated	marketed	Alpha-1 adrenergic receptor agonist	Alpha-1 adrenergic receptor
Norepinephrine intra-arteriel/hepatic	Norepinephrine intra-arteriel/hepatic	University Health Network, Toronto	marketed	Sympathomimetic amine / Adrenergic agonist	Alpha-1 adrenergic receptor, Beta-1 adrenergic receptor
Brompheniramine + pseudoephedrine	Brompheniramine + pseudoephedrine	Ache Laboratorios Farmaceuticos S.A.	marketed	Antihistamine + decongestant combination	H1 receptor (brompheniramine); alpha-1 adrenergic receptor (pseudoephedrine)
Placebo to Prazosin	Placebo to Prazosin	Brian J Lipworth	marketed	Alpha-1 adrenergic receptor antagonist	Alpha-1 adrenergic receptor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Sympathomimetic class)

Centre Hospitalier Universitaire, Amiens · 1 drug in this class
Shaheed Mohtarma Benazir Bhutto Institue of Trauma · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). noradrenaline and vascular filling — Competitive Intelligence Brief. https://druglandscape.com/ci/noradrenaline-and-vascular-filling. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab